Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Central and peripheral nervous system complications.

M R Brown, P J Dyck, G E McClearn

    Diabetes
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Regulation of food intake and body weight by insulin.

    Diabetologia·2016
    Same author

    Peptides and the control of meal size.

    Diabetologia·2016
    Same author

    Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab).

    Journal of the peripheral nervous system : JPNS·2014
    Same author

    Effect of fasting on regional levels of neuropeptide Y mRNA and insulin receptors in the rat hypothalamus: An autoradiographic study.

    Molecular and cellular neurosciences·2009
    Same author

    Diabetic neuropathy: pathogenetic background, current and future therapies.

    Expert review of neurotherapeutics·2009
    Same author

    Human C-peptide dose dependently prevents early neuropathy in the BB/Wor-rat.

    International journal of experimental diabetes research·2002
    Same journal

    Females Are Completely Resistant to Semaglutide-Induced Muscle Loss in ob/ob Mice.

    Diabetes·2026
    Same journal

    Ketone Bodies Derived From Medium-Chain Triglycerides Support Brain Metabolism and Function Under Hypoglycemia in Type 1 Diabetes Mellitus.

    Diabetes·2026
    Same journal

    Targeting the ADA/ADO Axis Rescues β-Cell Failure in Type 2 Diabetes.

    Diabetes·2026
    Same journal

    TXNIP Is Positioned as a Key Mediator of Hyperglycemia-Induced Vascular Senescence.

    Diabetes·2026
    Same journal

    Sex Differences in ER Stress Pathways Are a Key Determinant of β-Cell Proliferation and Resilience.

    Diabetes·2026
    Same journal

    The Mechanism of TNF-α Combined With High Glucose in Regulating Calnexin Aggravates Endoplasmic Reticulum Stress in Endothelial Cell Injury of Diabetic Retinopathy.

    Diabetes·2026
    See all related articles

    Diabetic neuropathy affects 10% of patients. Current animal models poorly mimic human diabetic neuropathy, necessitating better long-term studies using cross-disciplinary approaches for improved understanding.

    Area of Science:

    • Neurology
    • Diabetology
    • Animal Modeling

    Background:

    • Symptomatic neuropathy is a frequent complication of diabetes mellitus, impacting sensory, motor, or autonomic functions in about 10% of patients.
    • Animal models are crucial for investigating the metabolic and electrophysiologic aspects of diabetic neuropathy.

    Purpose of the Study:

    • To review the utility of existing animal models for studying human diabetic neuropathy.
    • To highlight the limitations of current models in fully replicating human diabetic neuropathy characteristics.
    • To recommend improved methodologies for future research.

    Main Methods:

    • Review of genetic, chemically induced, and nutritional animal models of diabetes mellitus.
    • Emphasis on the need for long-term evaluation of neuropathy characteristics.

    Related Experiment Videos

  • Recommendation for a cross-disciplinary approach incorporating biochemical, electrophysiologic, and morphologic techniques.

    • Main Results:

    • Existing animal models (e.g., Chinese hamster, ob/ob mouse, db/db mouse, BB-wistar rat, SSDR rat) have shown limited success in demonstrating key features of human diabetic neuropathy.
    • A significant gap exists between the characteristics observed in animal models and those seen in human patients.

    Conclusions:

    • Further research is needed to better characterize existing animal models of diabetic neuropathy.
    • Long-term studies employing a combination of biochemical, electrophysiologic, and morphologic analyses are recommended.
    • Development of more accurate animal models is essential for advancing the study and treatment of diabetic neuropathy.